CLNN

Clene (CLNN)

About Clene (CLNN)

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Details

Daily high
$5.57
Daily low
$5.27
Price at open
$5.57
52 Week High
$13.50
52 Week Low
$3.50
Market cap
68.2M
Dividend yield
0.00%
Volume
34,525
Avg. volume
58,891
P/E ratio
-1.66

Clene News

Details

Daily high
$5.57
Daily low
$5.27
Price at open
$5.57
52 Week High
$13.50
52 Week Low
$3.50
Market cap
68.2M
Dividend yield
0.00%
Volume
34,525
Avg. volume
58,891
P/E ratio
-1.66